Literature DB >> 33395627

Impact of Telemedicine on Patient Satisfaction and Perceptions of Care Quality in Radiation Oncology.

Narek Shaverdian1, Erin F Gillespie1, Elaine Cha1, Soo Young Kim2, Stephanie Benvengo1, Fumiko Chino1, Jung Julie Kang1, Yuelin Li2,3, Thomas M Atkinson2, Nancy Lee1, Charles M Washington1, Oren Cahlon1, Daniel R Gomez1.   

Abstract

BACKGROUND: The COVID-19 pandemic has transformed cancer care with the rapid expansion of telemedicine, but given the limited use of telemedicine in oncology, concerns have been raised about the quality of care being delivered. We assessed the patient experience with telemedicine in routine radiation oncology practice to determine satisfaction, quality of care, and opportunities for optimization. PATIENTS AND METHODS: Patients seen within a multistate comprehensive cancer center for prepandemic office visits and intrapandemic telemedicine visits in December 2019 through June 2020 who completed patient experience questionnaires were evaluated. Patient satisfaction between office and telemedicine consultations were compared, patient visit-type preferences were assessed, and factors associated with an office visit preference were determined.
RESULTS: In total, 1,077 patients were assessed (office visit, n=726; telemedicine, n=351). The telemedicine-consult survey response rate was 40%. No significant differences were seen in satisfaction scores between office and telemedicine consultations, including the appointment experience versus expectation, quality of physician's explanation, and level of physician concern and friendliness. Among telemedicine survey respondents, 45% and 34% preferred telemedicine and office visits, respectively, and 21% had no preference for their visit type. Most respondents found their confidence in their physician (90%), understanding of the treatment plan (88%), and confidence in their treatment (87%) to be better or no different than with an office visit. Patients with better performance status and who were married/partnered were more likely to prefer in-person office visit consultations (odds ratio [OR], 1.04 [95% CI, 1.00-1.08]; P=.047, and 2.41 [95% CI, 1.14-5.47]; P=.009, respectively). Patients with telephone-only encounters were more likely to report better treatment plan understanding with an office visit (OR, 2.25; 95% CI, 1.00-4.77; P=.04).
CONCLUSIONS: This study is the first to assess telemedicine in routine radiation oncology practice, and found high patient satisfaction and confidence in their care. Optimization of telemedicine in oncology should be a priority, specifically access to audiovisual capabilities that can improve patient-oncologist communication.

Entities:  

Year:  2021        PMID: 33395627      PMCID: PMC8254817          DOI: 10.6004/jnccn.2020.7687

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  34 in total

1.  Legal Perspectives on Telemedicine Part 1: Legal and Regulatory Issues.

Authors:  Christian D Becker; Katherine Dandy; Max Gaujean; Mario Fusaro; Corey Scurlock
Journal:  Perm J       Date:  2019-06-07

Review 2.  The Role of Telemedicine in Providing Thoracic Oncology Care to Remote Areas of British Columbia.

Authors:  Michael F Humer; Barbara G Campling
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

3.  Telemedicine for Cancer Care in the Time of COVID-19.

Authors:  Trevor J Royce; Hanna K Sanoff; Amar Rewari
Journal:  JAMA Oncol       Date:  2020-11-01       Impact factor: 31.777

4.  Assessing Telemedicine Unreadiness Among Older Adults in the United States During the COVID-19 Pandemic.

Authors:  Kenneth Lam; Amy D Lu; Ying Shi; Kenneth E Covinsky
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

5.  COVID-19 and cancer.

Authors:  Norman E Sharpless
Journal:  Science       Date:  2020-06-19       Impact factor: 47.728

6.  Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer.

Authors:  Chun Chieh Lin; Suanna S Bruinooge; M Kelsey Kirkwood; Dawn L Hershman; Ahmedin Jemal; B Ashleigh Guadagnolo; James B Yu; Shane Hopkins; Michael Goldstein; Dean Bajorin; Sharon H Giordano; Michael Kosty; Anna Arnone; Amy Hanley; Stephanie Stevens; Christine Olsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-17       Impact factor: 7.038

7.  Information needs of patients with cancer: results from a large study in UK cancer centres.

Authors:  V Jenkins; L Fallowfield; J Saul
Journal:  Br J Cancer       Date:  2001-01-05       Impact factor: 7.640

8.  COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.

Authors:  Lennard Yw Lee; Jean-Baptiste Cazier; Vasileios Angelis; Roland Arnold; Vartika Bisht; Naomi A Campton; Julia Chackathayil; Vinton Wt Cheng; Helen M Curley; Matthew W Fittall; Luke Freeman-Mills; Spyridon Gennatas; Anshita Goel; Simon Hartley; Daniel J Hughes; David Kerr; Alvin Jx Lee; Rebecca J Lee; Sophie E McGrath; Christopher P Middleton; Nirupa Murugaesu; Thomas Newsom-Davis; Alicia Fc Okines; Anna C Olsson-Brown; Claire Palles; Yi Pan; Ruth Pettengell; Thomas Powles; Emily A Protheroe; Karin Purshouse; Archana Sharma-Oates; Shivan Sivakumar; Ashley J Smith; Thomas Starkey; Chris D Turnbull; Csilla Várnai; Nadia Yousaf; Rachel Kerr; Gary Middleton
Journal:  Lancet       Date:  2020-05-28       Impact factor: 79.321

9.  COVID-19 in patients with lung cancer.

Authors:  J Luo; H Rizvi; I R Preeshagul; J V Egger; D Hoyos; C Bandlamudi; C G McCarthy; C J Falcon; A J Schoenfeld; K C Arbour; J E Chaft; R M Daly; A Drilon; J Eng; A Iqbal; W V Lai; B T Li; P Lito; A Namakydoust; K Ng; M Offin; P K Paik; G J Riely; C M Rudin; H A Yu; M G Zauderer; M T A Donoghue; M Łuksza; B D Greenbaum; M G Kris; M D Hellmann
Journal:  Ann Oncol       Date:  2020-06-17       Impact factor: 51.769

10.  The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.

Authors:  Camille Maringe; James Spicer; Melanie Morris; Arnie Purushotham; Ellen Nolte; Richard Sullivan; Bernard Rachet; Ajay Aggarwal
Journal:  Lancet Oncol       Date:  2020-07-20       Impact factor: 54.433

View more
  15 in total

1.  Telemedicine for outpatient palliative care during COVID-19 pandemics: a longitudinal study.

Authors:  Augusto Caraceni; Chiara Pellegrini; Morena Shkodra; Ernesto Zecca; Paola Bracchi; Silvia Lo Dico; Mariangela Caputo; Simonetta Zappata; Emanuela Zito; Cinzia Brunelli
Journal:  BMJ Support Palliat Care       Date:  2022-06-16       Impact factor: 4.633

2.  Bias in Patient Experience Scores in Radiation Oncology: A Multicenter Retrospective Analysis.

Authors:  Elaine Cha; Noah J Mathis; Himanshu Joshi; Sonam Sharma; Melissa Zinovoy; Meng Ru; Oren Cahlon; Erin F Gillespie; Deborah C Marshall
Journal:  J Am Coll Radiol       Date:  2022-03-02       Impact factor: 6.240

3.  Future of Teleoncology: Trends and Disparities in Telehealth and Secure Message Utilization in the COVID-19 Era.

Authors:  Elad Neeman; Liisa Lyon; Hongxin Sun; Carol Conell; Mary Reed; Deepika Kumar; Tatjana Kolevska; Dinesh Kotak; Tilak Sundaresan; Raymond Liu
Journal:  JCO Clin Cancer Inform       Date:  2022-03

4.  Cancer patients' satisfaction with telehealth during the COVID-19 pandemic.

Authors:  Samantha R Paige; Gemme Campbell-Salome; Jordan Alpert; Merry Jennifer Markham; Martina Murphy; Eve Heffron; Chris Harle; Sijia Yue; Wei Xue; Carma L Bylund
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

5.  The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.

Authors:  Paolo A Ascierto; Allison Betof Warner; Christian Blank; Corrado Caracò; Sandra Demaria; Jeffrey E Gershenwald; Nikhil I Khushalani; Georgina V Long; Jason J Luke; Janice M Mehnert; Caroline Robert; Piotr Rutkowski; Hussein A Tawbi; Iman Osman; Igor Puzanov
Journal:  J Transl Med       Date:  2022-05-10       Impact factor: 8.440

6.  Telemedicine Use and Satisfaction Among Radiation Oncologists During the COVID-19 Pandemic: Evaluation of Current Trends and Future Opportunities.

Authors:  Nicholas J Damico; Alok Deshane; Michael Kharouta; Anna Wu; Gi-Ming Wang; Mitchell X Machtay; Aryavarta Kumar; Serah Choi; Aashish D Bhatt
Journal:  Adv Radiat Oncol       Date:  2021-10-27

Review 7.  The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review.

Authors:  Adam Suleman; Abi Vijenthira; Alejandro Berlin; Anca Prica; Danielle Rodin
Journal:  Curr Oncol       Date:  2022-02-07       Impact factor: 3.677

8.  Disparities in telemedicine during COVID-19.

Authors:  Alexander S Qian; Melody K Schiaffino; Vinit Nalawade; Lara Aziz; Fernanda V Pacheco; Bao Nguyen; Peter Vu; Sandip P Patel; Maria Elena Martinez; James D Murphy
Journal:  Cancer Med       Date:  2022-01-05       Impact factor: 4.452

9.  Development and Pilot Implementation of a Remote Monitoring System for Acute Toxicity Using Electronic Patient-Reported Outcomes for Patients Undergoing Radiation Therapy for Breast Cancer.

Authors:  Kaitlyn Lapen; Christopher Sabol; Amy L Tin; Kathleen Lynch; Alyse Kassa; Xiaolin Mabli; John Ford; Elaine Cha; Michael B Bernstein; Lior Z Braunstein; Oren Cahlon; Bobby M Daly; Kiri Sandler; Susan A McCloskey; Andrew J Vickers; Atif J Khan; Erin F Gillespie
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-07-24       Impact factor: 7.038

10.  Economic distress, financial toxicity, and medical cost-coping in young adult cancer survivors during the COVID-19 pandemic: Findings from an online sample.

Authors:  Bridgette Thom; Catherine Benedict; Danielle N Friedman; Samantha E Watson; Michelle S Zeitler; Fumiko Chino
Journal:  Cancer       Date:  2021-08-05       Impact factor: 6.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.